PP2A's restraint of mTOR is critical for Treg cell activity

被引:8
|
作者
Delgoffe, Greg M. [1 ,2 ]
机构
[1] Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA
关键词
PHOSPHATASE PP2A; KINASE;
D O I
10.1038/ni.3442
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells must limit activation of the metabolic checkpoint kinase mTOR to maintain their identity. The lipid ceramide serves a unique role in this process by inducing phosphatase PP2A-mediated inhibition of the mTORC1 complex.
引用
收藏
页码:478 / 479
页数:3
相关论文
共 44 条
  • [31] S-Equol ameliorates insulin secretion failure through Chrebp/Txnip signaling via modulating PKA/PP2A activities
    Chen, Ka
    Lang, Hedong
    Wang, Li
    Liu, Kai
    Zhou, Yong
    Mi, Mantian
    NUTRITION & METABOLISM, 2020, 17 (01)
  • [32] CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
    Lucas, Claire M.
    Scott, Laura J.
    Carmell, Natasha
    Holcroft, Alison K.
    Hills, Robert K.
    Burnett, Alan K.
    Clark, Richard E.
    BLOOD ADVANCES, 2018, 2 (09) : 964 - 968
  • [33] An AMBRA1, ULK1 and PP2A regulatory network regulates cytotoxic T cell differentiation via TFEB activation
    Migliore, Loredana
    Cianfanelli, Valentina
    Zevolini, Fabrizia
    Gesualdo, Monica
    Marzuoli, Leandro
    Patrussi, Laura
    Ulivieri, Cristina
    Marotta, Giuseppe
    Cecconi, Francesco
    Finetti, Francesca
    Baldari, Cosima T.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [34] Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells
    Ozel, Buket
    Kipcak, Sezgi
    Avci, Cigir Biray
    Gunduz, Cumhur
    Saydam, Guray
    Aktan, Cagdas
    Gunel, Nur Selvi
    MEDICAL ONCOLOGY, 2022, 39 (04)
  • [35] Regulation of the stability and activity of CDC25A and CDC25B by protein phosphatase PP2A and 14-3-3 binding
    Kohama, Yuri
    Saito, Megumi
    Yada, Mizue
    Sakurai, Hiroshi
    CELLULAR SIGNALLING, 2019, 54 : 10 - 16
  • [36] Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer's Disease
    Tyagi, Arti
    Kamal, Mohammad A.
    Poddar, Nitesh Kumar
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [37] IL-17A's role in exacerbating radiation-induced lung injury: Autophagy impairment via the PP2A-mTOR pathway
    Liu, Liangzhong
    Yi, Guangming
    Li, Xiaohong
    Chen, Cai
    Chen, Kehong
    He, Hengqiu
    Li, Jinjin
    Cai, Fanghao
    Peng, Yuan
    Yang, Zhenzhou
    Zhang, Xiaoyue
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2025, 1872 (01):
  • [38] Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells
    Zeng, Qingyu
    Zhang, Hai
    Qin, Jiamin
    Xu, Zhigang
    Gui, Lin
    Liu, Beibei
    Liu, Chunxiao
    Xu, Chong
    Liu, Wen
    Zhang, Shuangquan
    Huang, Shile
    Chen, Long
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (24) : 4867 - 4884
  • [39] Cryptotanshinone Prevents the Binding of S6K1 to mTOR/Raptor Leading to the Suppression of mTORC1-S6K1 Signaling Activity and Neoplastic Cell Transformation
    Jeoung, Nam Ho
    Jeong, Ji Yun
    Kang, Bong Seok
    JOURNAL OF CANCER PREVENTION, 2021, 26 (02) : 145 - 152
  • [40] Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions
    Li, Xin
    Acuff, Nicole V.
    Peeks, Angela R.
    Kirkland, Rebecca
    Wyatt, Kara D.
    Nagy, Tamas
    Watford, Wendy T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (32) : 16802 - 16815